Impact

Georgetown Lombardi is at the forefront of pioneering research known as immunotherapy. Immunotherapy uses your body’s immune system to find and destroy cancerous cells. There are several different immunotherapy types, but all immunotherapy works by training your immune system so it can do more to fight cancer.

Georgetown Lombardi’s Office of Minority Health and Health Disparities Research continues to make great strides in the fight against cancer, implementing effective interventions in the capital that support disproportionately impacted populations through navigational services, screenings, educational programs, and other preventative measures.

Georgetown Lombardi is a leader in an emerging approach for cancer research, treatment, and prevention called precision medicine. Precision medicine considers individual variability in genes, environment, and lifestyle for each person allowing our team to treat the right cancer with the right medication at the right time.

Survivorship research includes studying cancer treatment side effects and surveillance for second cancers. Survivorship research also includes studies of health care delivery, or how cancer care and primary care can work together after treatment. It spans cancer types and specialties. At Georgetown Lombardi, our goal is to generate standards of care to serve as models in Washington, D.C. and beyond.

Georgetown Lombardi is recognizing the critical role of large, complex data sets to the cancer center’s research progress, Georgetown Lombardi launched the Innovation Center for Biomedical Informatics (ICBI) as an academic hub for innovative research in this field. Leveraging the power of advanced analytics, machine learning, and artificial intelligence, ICBI better connects patients to innovative cancer treatments while ensuring cutting-edge research can be shared seamlessly across research institutions and the private sector.